RNS Number : 8706J
Leeds Group PLC
29 April 2022
 

29 April 2022

Leeds Group plc

(the "Company")

 

Trading Update

 

In the Interim Statement announced on 17 January 2022, the Company commented that the Covid-19 pandemic continued to impact trading activities, with revenues in both trading companies, Hemmers/Itex Textil Import Export GmbH and Stoff Ideen KMR GmbH, having been significantly reduced in the first half of the year compared with the previous year.

 

This trend has continued in the second half of the year, despite the easing of Covid-19 restrictions, with consumer confidence further affected by the recent conflict in Ukraine and its impact on domestic expenditures.

 

As indicated in the Interim Statement announcement, management has taken steps to reduce costs to reflect reduced activity levels and these efforts will continue. The Company does not expect the German government to provide any further financial support schemes as Germany is no longer in a lockdown situation. Management is currently undertaking an operational review of both businesses to assess what further actions need to be taken to return the Company to profit.

 

This announcement contains inside information for the purposes of UK Market Abuse Regulation and has been arranged for release by Jan G Holmstrom, Chairman.

 

Enquiries:

 

Leeds Group plc

Dawn Henderson

Tel:  01937 547877

Cairn Financial Advisers LLP

Nominated Adviser

Liam Murray / Sandy Jamieson

Tel:  020 7213 0880

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTILMLTMTBTMFT